Skip to main content
. Author manuscript; available in PMC: 2019 Jun 27.
Published in final edited form as: Nat Rev Gastroenterol Hepatol. 2019 Mar;16(3):175–184. doi: 10.1038/s41575-018-0087-5

Table 1 |.

prevention levels and targets applied to pancreatitis

primary prevention Secondary prevention Tertiary prevention
First acute pancreatitis episode
Prevention strategies • Education of general population
• Avoidance of high-risk medications and futile ERCP
• Effective algorithms for early identification and effective in-hospital management of AP • Screening of patients at high risk
Intervention objectives • Reducing heavy alcohol use, smoking and obesity
• Increasing intake of vegetables
• Judicious use of drugs known to induce AP
• Restricted use of ERCP
• Early detection of AP and removal of known aetiologies (for example, cholecystectomy, control triglycerides, discontinuation of drugs that induced AP, alcohol, smoking)
• Judicious use of opiates, nutrition and fluids to prevent progression of AP severity
• Early detection and management of sequelae (for example, PPDM, EPI) via regular follow-ups
• Administration of preventative medications (for example, metformin for PPDM)a
Responsible sector • Public health specialists
• Primary care physicians
• Gastroenterologists
• Primary care physicians
• Gastroenterologists
• Surgeons
• Radiologists
• Primary care physicians
• Gastroenterologists
• Dietitians
• Endocrinologists
Recurrent acute pancreatitis
Prevention strategies • Education of general population and individuals with prior attack of AP • Effective in-hospital management of AP • Screening of high-risk patients
Intervention objectives • Reducing heavy alcohol use, smoking and obesity
• Increasing intake of vegetables
• Judicious use of drugs known to induce AP
• Avoidance of futile ERCP
• Administration of preventative medications (for example, statins)a
• Removal of known aetiologies (for example, cholecystectomy, control triglycerides, discontinuation of drugs that induced AP, alcohol, smoking)
• Judicious use of opiates, nutrition and fluids to prevent progression of AP severity
• Early detection and management of sequelae (for example, PPDM, EPI) via regular follow-ups
• Administration of preventative medications (for example, metformin for PPDM)a
Responsible sector • Public health specialists
• Primary care physicians
• Gastroenterologists
• Surgeons
• Gastroenterologists
• Surgeons
• Primary care physicians
• Gastroenterologists
• Dietitians
• Endocrinologists
Chronic pancreatitis
Prevention strategies • Education of general population and individuals with prior attack of AP • Effective algorithms of early identification of CP • Screening of high-risk patients
• Professional health consultancy for patients with CP
• Chronic pain management
Intervention objectives • Reducing heavy alcohol use, smoking and obesity
• Increasing intake of vegetables
• Administration of preventive medications (for example, statins)a
• Early detection of CP
• Removal of known aetiologies (for example, alcohol, smoking)
• Treatment of pancreatic strictures and stones
• Discontinuation of alcohol and smoking
• Early detection and management of sequelae (for example, PPDM, EPI) via regular follow-ups
• Patient behaviour change
• Administration of preventative medications (for example, calcium and vitamin D for osteoporosis, metformin for PPDMa)
Responsible sector • Public health specialists
• Primary care physicians
• Gastroenterologists
•Surgeons
• Primary care physicians
• Gastroenterologists
• Surgeons
• Radiologists
• Primary care physicians
• Gastroenterologists
• Endocrinologists
• Pain specialists
• Dietitians

AP, acute pancreatitis; CP, chronic pancreatitis; EPI, exocrine pancreatic insufficiency; ERCP, endoscopic retrograde cholangiopancreatography; PPDM, post-pancreatitis diabetes mellitus.

a

lf confirmed in future studies.

HHS Vulnerability Disclosure